Aragen’s biologics manufacturing facility completes qualification; first GMP batches in late July 2025

12 June, 2025 – Morgan Hill, California: Aragen, a leading contract research, development and manufacturing organization (CRDMO), announced that it will commence GMP manufacturing at its biologics manufacturing facility in Bangalore, India from late July 2025.  Aragen has successfully completed the facility and equipment qualification and demonstrated the productivity of its intensified fed batch cell culture manufacturing platform to deliver titers >25 g/L.

Aragen’s biologics manufacturing facility completes qualification; first GMP batches in late July 2025